Crisanta (Yasmin)3 0.03mg

$15.75

Each Crisanta contains 21 pills of Drospirenone & Ethinel Estradiol hormone. It is used as a birth control for women and for treating acne in females.

ATC Classification: G03AA12
Active Ingrediant: Drospirenone & Ethinel Estradiol
Generic Name: Crisanta
Manufacturer: Cipla Limited
Strength: 3 0.03mg
Dosage Type: Tablet
Packaging Type: Blister in Box
Contains: 21 Tab

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Crisanta (Yasmin)3 0.03mg
$15.75

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Medication Safety Issues

Sound-alike/look-alike issues:

Yaz may be confused with Beyaz, Yasmin

 

Storage/Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

 

Adverse Reactions

Frequency not defined. Reactions listed are based on reports for other agents in this same pharmacologic class (oral contraceptives) and may not be specifically reported for drospirenone/ethinyl estradiol.

Increased risk or evidence of association with use:

Cardiovascular: Arterial thromboembolism, cerebral thrombosis, hypertension, local thrombophlebitis, mesenteric thrombosis, myocardial infarction, pulmonary embolism, retinal thrombosis

Central nervous system: Cerebral hemorrhage

Gastrointestinal: Gallbladder disease

Hepatic: Hepatic adenoma, hepatic neoplasm (benign)

Adverse reactions considered drug related:

Cardiovascular: Edema, worsening of varicose veins

Central nervous system: Depression, exacerbation of tics, migraine

Dermatologic: Allergic skin rash, chloasma

Endocrine & metabolic: Amenorrhea, breast changes (breast hypertrophy, breast secretion, breast tenderness, mastalgia), decreased serum folate level, exacerbation of porphyria, menstrual disease (menstrual flow changes), weight changes

Gastrointestinal: Abdominal cramps, bloating, carbohydrate intolerance, nausea, vomiting

Genitourinary: Breakthrough bleeding, cervical ectropion, cervical erosion, change in cervical secretions, decreased lactation (with use immediately postpartum), infertility (temporary), spotting, vulvovaginal candidiasis

Hepatic: Cholestatic jaundice

Hypersensitivity: Anaphylaxis/anaphylactoid reaction (including angioedema, circulatory shock, respiratory collapse, urticaria)

Neuromuscular & skeletal: Exacerbation of systemic lupus erythematosus

Ophthalmic: Change in corneal curvature (steepening), contact lens intolerance

Adverse reactions in which association is not confirmed or denied:

Cardiovascular: Budd-Chiari syndrome

Central nervous system: Dizziness, headache, nervousness

Dermatologic: Acne vulgaris, erythema multiforme, erythema nodosum, loss of scalp hair

Endocrine & metabolic: Change in libido, hirsutism, porphyria, premenstrual syndrome

Gastrointestinal: Change in appetite, colitis, pancreatitis

Genitourinary: Cystitis-like syndrome, dysmenorrhea, vaginitis

Hematologic & oncologic: Hemolytic-uremic syndrome, hemorrhagic eruption

Ophthalmic: Cataract, optic neuritis (with or without partial or complete loss of vision)

Renal: Renal insufficiency

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type